Barclays PLC Journey Medical Corp Transaction History
Barclays PLC
- $436 Billion
- Q2 2025
A detailed history of Barclays PLC transactions in Journey Medical Corp stock. As of the latest transaction made, Barclays PLC holds 22,403 shares of DERM stock, worth $164,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,403
Previous 22,403
-0.0%
Holding current value
$164,662
Previous $161,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
62Shares Held
7MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$13.6 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$8.47 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$6.36 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA565KShares$4.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA262KShares$1.93 Million0.0% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $85.2M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...